Catalyst Pharmaceuticals (CPRX) Inventory (2018 - 2026)

Catalyst Pharmaceuticals (CPRX) has 9 years of Inventory data on file, last reported at $34.9 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory rose 76.61% year-over-year to $34.9 million; the trailing twelve-month figure through Mar 2026 stood at $34.9 million (up 76.61% YoY), and the FY2025 full-year result was $37.2 million, up 90.19% from the prior year.
• Inventory for Q1 2026 stood at $34.9 million, down from $37.2 million in the prior quarter.
• Across five years, Inventory topped out at $37.2 million in Q4 2025 and bottomed at $6.8 million in Q4 2022.
• The 5-year median for Inventory is $18.0 million (2024), against an average of $17.1 million.
• The widest annual swing landed in 2022, when Inventory declined 13.53%; it then surged 129.89% in 2023.
• A 5-year view of Inventory shows it stood at $6.8 million in 2022, then surged by 129.89% to $15.6 million in 2023, then rose by 24.91% to $19.5 million in 2024, then jumped by 90.19% to $37.2 million in 2025, then slipped by 6.02% to $34.9 million in 2026.
• The last three Inventory figures came in at $34.9 million (Q1 2026), $37.2 million (Q4 2025), and $28.0 million (Q3 2025), per Business Quant data.

Peer Comparison